Recent research have focused on the convergence of GLP-1|glucose-dependent insulinotropic polypeptide|GCGR agonist therapies and DA communication. While GIP agonists are commonly employed for addressing type 2 diabetes mellitus, their emerging consequences on motivation circuits, specifically inf